SMi’s 4th annual conference on Pharmacovigilance, Drug Safety & Risk Management will take place on the 11th & 12th May 2015 in London UK.
LONDON -
(EINPresswire via NewMediaWire) - March 17, 2015 - According to a new study the global pharmacovigilance market is estimated to be worth US$5,008.2 million by the end of 2019. Stringent government regulations, issues pertaining to public safety, toughened inspection regimes, coupled with the need of patients to report ailments immediately, has propelled growth in the global pharmacovigilance market.*
Attendees at SMi’s Pharmacovigilance, Drug Safety & Risk Management conference will have the perfect opportunity to share knowledge in risk assessment strategies and raise standards in drug safety at when it returns to London this May for its 4th annual show. This event will enable delegates to develop their position in a competitive growing market by hearing the latest updates on good pharmacovigilance practice through keynote sessions delivered by an esteemed panel of speakers including PharSafer Associates, Takeda, Quintiles, MedDRA, PRAC, Novartis and Pfizer. Latest attendees include ProductLife Ltd, TEVA Pharmaceuticals and Roche Products Limited.
Highlights will include a Day 2 opening keynote address from industry experts, Symogen who’s clients include Roche, Pharma, Eisai, Glenmark and Astellas. Executive Director & QPPV, Dr Pipasha Biswas, will be discussing active surveillance with a focus on ADR’S, the drivers and restraints in pharmacovigilance, imperfect data and corporate responsibility.
In addition to the event, there will be 2 workshops taking place on the 13th May 2015 entitled: MedDRA Coding Guidelines, hosted by Dr. Tomas Moraleda, International Medical Officer, MedDRA MSSO and Risk Minimisation and Signal Management, hosted by Graeme Ladds, CEO, Director of Operations, Pharmacovigilance, PharSafer Associates Ltd.
For those who are interested in attending the event there will be a £100 discount. For more information and to register visit http://www.smi-online.co.uk/goto/2015pharmacovigilance1.asp
*Source: http://bit.ly/18BYIUg
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Teri Arri
SMi Group Ltd
+442078276162